Q2 2025 Resmed Inc Earnings Call
Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...
ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
thorax.bmj4d
A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome
Trial registration number ACTRN12611000874910, results. Australian trial finds that CPAP provides similar benefits to non-invasive ventilation in severe obesity hypoventilation syndrome. Contributors ...
thorax.bmj4d
Long-term survival following initiation of home non-invasive ventilation: a European study
gstt.nhs.uk Introduction Although home non-invasive ventilation (NIV ... We excluded all patients set up on CPAP, adaptive servo-ventilation and patients receiving invasive ventilation via ...
Global Sleep Apnea Devices Market Size To Hit USD 9.43 Billion By 2032, Growing At A CAGR Of 6.74% - SNS Insider
Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032, growing ...
Managed Healthcare Executive1d
5 Questions For Respiratory Therapist Educator Brandan Gerry
The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...
HME News24d
VGM ‘fills gap’ in respiratory offering
WATERLOO, Iowa – VGM Group has acquired SleepGlad, a secure, 3D mask-fitting platform for CPAP and non-invasive ventilators, from Baxter Technologies in a move that fills out the company’s respiratory ...